🏛️ Verified NIH Record • Updated 2026-06-17
Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN) (NCT04874038)
🟢 Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: University Health Network, Toronto
🩺 Plain-English Summary (8th-Grade Level)
Phase III, international multicentre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of an intraoperative intravenous lidocaine infusion on reducing the development of persistent pain 3-months after breast cancer surgery.
Who can join: Review the eligibility criteria below.
Location: Foothills Medical Centre — Calgary, Alberta
Age range: 18 Years to 100 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (17 Sites)
- Foothills Medical Centre — Calgary, Alberta
- Sturgeon Community Hospital — Edmonton, Alberta
- Eastern Health- Health Sciences Centre — St. John's, Newfoundland and Labrador
- IWK — Halifax, Nova Scotia
- Juravinski Hospital — Hamilton, Ontario
- North York General Hospital — North York, Ontario
- The Ottawa Hospital — Ottawa, Ontario
- Thunder Bay Regional Health Sciences Centre — Thunder Bay, Ontario
- Humber River Hospital — Toronto, Ontario
- Mount Sinai Hospital — Toronto, Ontario
- St. Michael's Hospital — Toronto, Ontario
- Sunnybrook Health Sciences Centre — Toronto, Ontario
- University Health Network — Toronto, Ontario
- Women's College Hospital — Toronto, Ontario
- Hôpital Maisonneuve-Rosemont — Montreal, Quebec
- B.P. Koirala Institute of Health Sciences — Dharān,
- Obafemi Awolowo University Teaching Hospitals Complex — Ile-Ife,
📞 Contact the Study Coordinator
Phone: (416) 340-4800
Email: James.Khan@medportal.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Post-mastectomy Pain Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.